Royal Bank of Canada
ZJYL

Royal Bank of Canada’s Jin Medical International ZJYL Stock Holding History

Royal Bank of Canada’s Portfolio ZJYL Stock Details ZJYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32
Closed -$2K – 7317
2024
Q3 		$2K Buy
+32
New +$1.92K ﹤0.01% 6666

Other funds holding ZJYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIA
Bell Investment Advisors Oakland, California $681M AUM 18.36% 1-Year Est. Return
W
WealthCollab Bellevue, Washington $276M AUM 33.83% 1-Year Est. Return

Royal Bank of Canada's ZJYL Position: Q4 2024 in Review

Royal Bank of Canada sold out of Jin Medical International (ZJYL) in Q4 2024, closing a stake of 32 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in ZJYL in Q3 2024 and held it in 1 quarter. The position peaked at $2K in Q3 2024. 10 funds tracked by Wall St. Rank hold ZJYL as of Q4 2024.

  • Royal Bank of Canada reported no remaining Jin Medical International position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 32 Jin Medical International shares in Q4 2024, an estimated $2K.
  • Royal Bank of Canada first reported a position in Jin Medical International in Q3 2024 and held it in 1 quarter.
  • Royal Bank of Canada's Jin Medical International position peaked at $2K in Q3 2024.
  • 10 funds tracked by Wall St. Rank held Jin Medical International as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.